250 related articles for article (PubMed ID: 32881046)
1. Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease.
Luber RP; Dawson L; Munari S; Kariyawasam VC; Martin C; Gibson PR; Sparrow MP; Ward MG
J Gastroenterol Hepatol; 2021 Apr; 36(4):990-998. PubMed ID: 32881046
[TBL] [Abstract][Full Text] [Related]
2. Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease.
Kariyawasam VC; Ward MG; Blaker PA; Patel KV; Goel R; Sanderson JD; Irving PM
Inflamm Bowel Dis; 2017 Sep; 23(9):1555-1565. PubMed ID: 28786865
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.
Yarur AJ; Kubiliun MJ; Czul F; Sussman DA; Quintero MA; Jain A; Drake KA; Hauenstein SI; Lockton S; Deshpande AR; Barkin JS; Singh S; Abreu MT
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1118-24.e3. PubMed ID: 25562796
[TBL] [Abstract][Full Text] [Related]
5. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
6. Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease.
Feng R; Guo J; Zhang SH; Qiu Y; Chen BL; He Y; Zeng ZR; Ben-Horin S; Chen MH; Mao R
J Gastroenterol Hepatol; 2019 Apr; 34(4):679-685. PubMed ID: 30175864
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease.
Poon SS; Asher R; Jackson R; Kneebone A; Collins P; Probert C; Dibb M; Subramanian S
J Crohns Colitis; 2015 Aug; 9(8):640-6. PubMed ID: 25968584
[TBL] [Abstract][Full Text] [Related]
8. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
[TBL] [Abstract][Full Text] [Related]
9. A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease.
Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
J Crohns Colitis; 2018 Feb; 12(3):298-305. PubMed ID: 29145599
[TBL] [Abstract][Full Text] [Related]
10. 6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's Disease.
Mao R; Guo J; Luber R; Chen BL; He Y; Zeng ZR; Ben-Horin S; Sparrow MP; Roblin X; Chen MH
Inflamm Bowel Dis; 2018 Nov; 24(12):2621-2627. PubMed ID: 29788262
[TBL] [Abstract][Full Text] [Related]
11. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
Yarur AJ; Gondal B; Hirsch A; Christensen B; Cohen RD; Rubin DT
J Clin Gastroenterol; 2018 Jul; 52(6):537-544. PubMed ID: 28723860
[TBL] [Abstract][Full Text] [Related]
12. Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.
Thomsen SB; Allin KH; Burisch J; Jensen CB; Hansen S; Gluud LL; Theede K; Kiszka-Kanowitz M; Nielsen AM; Jess T
United European Gastroenterol J; 2020 Feb; 8(1):68-76. PubMed ID: 32213059
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
14. Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab.
Sousa P; Patita M; Arroja B; Lago P; Rosa I; de Sousa HT; Ministro P; Mocanu I; Vieira A; Castela J; Moleiro J; Roseira J; Cancela E; Portela F; Correia L; Santiago M; Dias S; Alves C; Afonso J; Dias CC; Magro F
Dig Liver Dis; 2024 May; 56(5):737-743. PubMed ID: 37980274
[TBL] [Abstract][Full Text] [Related]
15. The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
Gao X; Zhang FB; Ding L; Liu H; Wang XD; Chen BL; Bi HC; Xiao YL; Zhao LZ; Chen MH; Huang M; Hu PJ
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):958-64. PubMed ID: 22664938
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
Spencer E; Norris E; Williams C; Dubinsky MC
Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
[TBL] [Abstract][Full Text] [Related]
18. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines.
Bar-Yoseph H; Waterman M; Almog R; Billiet T; Vermeire S; Ungar B; Yanai H; Dotan I; Ben-Horin S; Chowers Y
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):69-75. PubMed ID: 27404966
[TBL] [Abstract][Full Text] [Related]
20. 6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease.
Neurath MF; Kiesslich R; Teichgräber U; Fischer C; Hofmann U; Eichelbaum M; Galle PR; Schwab M
Clin Gastroenterol Hepatol; 2005 Oct; 3(10):1007-14. PubMed ID: 16234047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
